# Autologous Bone Marrow Stem Cells in Middle Cerebral Artery Acute Stroke Treatment.

> **NCT00761982** · PHASE1,PHASE2 · COMPLETED · sponsor: **Hospital Universitario Central de Asturias** · enrollment: 20 (estimated)

## Conditions studied

- Stroke, Acute
- Infarction, Middle Cerebral Artery

## Interventions

- **PROCEDURE:** Infusion on autologous CD34+ stem cells into middle cerebral artery

## Key facts

- **NCT ID:** NCT00761982
- **Lead sponsor:** Hospital Universitario Central de Asturias
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2011-08
- **Final completion:** 2011-08
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2011-11-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00761982

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00761982, "Autologous Bone Marrow Stem Cells in Middle Cerebral Artery Acute Stroke Treatment.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00761982. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*